FCMV
Foresite Capital Management V Portfolio holdings
AUM
$80.7M
This Quarter Return
+24.3%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
–
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
(+5.1%)
Cap. Flow
+$814K
Cap. Flow
% of AUM
0.6%
Top 10 Holdings %
Top 10 Hldgs %
99.8%
Holding
11
New
–
Increased
2
Reduced
2
Closed
–
Top Buys
| 1 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$6.88M |
| 2 |
Quantum-Si Incorporated
QSI
|
$44 |
Top Sells
| 1 |
Hims & Hers Health
HIMS
|
$3.06M |
| 2 |
Compass Therapeutics
CMPX
|
$3.01M |
Sector Composition
| 1 | Healthcare | 72.62% |
| 2 | Consumer Staples | 27.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Hims & Hers Health
HIMS
$9.57B
| $37M | 27.38% | 3,733,381 -308,002 | -8% | -$3.06M |
|
|
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $31.8M | 23.54% | 3,585,346 | – | – |
|
|
PRDS
3
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $13.3M | 9.79% | 10,037,935 | – | – |
|
|
KNTE
4
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $12.3M | 9.13% | 1,975,001 +1,100,000 | +126% | +$6.88M |
|
|
5
Compass Therapeutics
CMPX
$483M
| $11.4M | 8.41% | 3,480,723 -919,277 | -21% | -$3.01M |
|
6
Aclaris Therapeutics
ACRS
$209M
| $10.2M | 7.52% | 1,258,243 | – | – |
|
|
SLGC
7
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $8.97M | 6.63% | 3,516,472 | – | – |
|
8
Disc Medicine
IRON
$2.07B
| $5.16M | 3.81% | 243,513 | – | – |
|
9
Adicet Bio
ACET
$59.9M
| $3.22M | 2.38% | 558,636 | – | – |
|
|
10
Quantum-Si Incorporated
QSI
$227M
| $1.63M | 1.2% | 924,404 +25 | +0% | +$44 |
|
11
Pharvaris
PHVS
$1.39B
| $275K | 0.2% | 34,142 | – | – |
|